Frequency and type of arrhythmia in Holter electrocardiogram in patients undergoing hemodialysis

Hemodialysis patients – arrhythmia

Authors

Keywords:

arrhythmia, Holter ECG, hemodialysis, frequency

Abstract

Background/Aim: It is known that approximately 40% of chronic hemodialysis patients die due to cardiac arrhythmia and cardiovascular reasons. Determining whether the hemodialysis procedure poses a risk for arrhythmia is important in terms of prognostic follow-up of the patients. Therefore, we aimed to determine the underlying arrhythmia frequency and types with 24-hour Holter electrocardiogram (ECG) in patients receiving hemodialysis with normal baseline electrocardiography between the hemodialysis periods.

Methods: Between January 2018 and January 2022, 91 consecutive patients who received hemodialysis for chronic renal failure (CRF) and applied to the cardiology outpatient clinic with complaints of palpitation and sinus rhythm on ECG and evaluated with 24-hour rhythm Holter ECG were included in the study. Our study was designed as a retrospective cohort study.

Results: The mean age of the patient population was 65.78 (11.92) years, the mean systolic blood pressure was 143.71 (24.88) mmHg, and the mean heart rate was 83.43 (15.85) beats/min. Hypertension (HT) (n=44, 48%) and coronary artery disease (n=34, 37%) were the most common comorbid diseases. The most common arrhythmias detected on Holter ECG were ventricular extrasystole (VES) (n=18, 19.8%) and paroxysmal AF (n=8, 8.8%). Non-sustained ventricular tachycardia was detected in two patients.

Conclusion: Detecting arrhythmia in the interdialytic periods in patients receiving hemodialysis due to CRF is important for follow-up and treatment. Even if the baseline ECG is normal in hemodialysis patients with CRF, the frequency of the underlying arrhythmia that needs to be treated is high.

Downloads

Download data is not yet available.

References

US Renal Data System. USRDS 2018 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2018.

Chertow GM, Block GA, Rotter RC, Drüeke TB, Floege J, Goodman WG, et al. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. New England Journal Medicine 2012;367:2482–94. DOI: https://doi.org/10.1056/NEJMoa1205624

Wanner C, Krane V, Marz W, Olschewski W, Mann JF, Ruf G, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. New England Journal Medicine 2005;353:238–48. DOI: https://doi.org/10.1056/NEJMoa043545

Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, et al. The Framingham predictive instrument in chronic kidney disease. Journal American College Cardiology 2007;50:217–24. DOI: https://doi.org/10.1016/j.jacc.2007.03.037

Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney International 2002;62:1524–38. DOI: https://doi.org/10.1046/j.1523-1755.2002.00600.x

McIntyre CW, Burton JO, Selby NM, Leccisotti L, Korsheed S, Baker CS, Camici PG: Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clinical Journal of the American Society of Nephrology 2008;3:19–26. DOI: https://doi.org/10.2215/CJN.03170707

Charytan DM, Padera R, Helfand AM, Zeisberg M, Xu X, Liu X, et al. Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease. International Journal of Cardiology 2014;176:99–109. DOI: https://doi.org/10.1016/j.ijcard.2014.06.062

Foley RN, Gilbertson DT, Murray T, Collins AJ. Long interdialytic interval and mortality among patients receiving hemodialysis. New England Journal Medicine 2011;365:1099–107. DOI: https://doi.org/10.1056/NEJMoa1103313

Pun PH, Lehrich RW, Honeycutt EF, Herzog CA, Middleton JP. Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. Kidney International 2011;79:218-27. DOI: https://doi.org/10.1038/ki.2010.315

Shimada K, Tomita T, Kamijo Y, Higuchi M, Ito K, Koizumi Y, et al. Hemodialysis-induced P-wave signal-averaged electrocardiogram alterations are indicative of vulnerability to atrial arrhythmias. Circulation Journal 2012;76:612–7. DOI: https://doi.org/10.1253/circj.CJ-11-1000

Makaryus AN. Ventricular arrhythmias in dialysis patients. Rev Cardiovasc Med. 2006 Winter;7(1):17-22. PMID: 16534492.

London G, Parfrey PS. Cardiac disease in chronic uremia: pathogenesis. Advances in Renal Replace Therapy 1997;4:194–211. DOI: https://doi.org/10.1016/S1073-4449(97)70029-3

Wizemann V, Kramer W, Funke T, Schütterle G. Dialysis induced cardiac arrhythmias: fact or fiction? Importance of preexisting cardiac disease in the induction of arrhythmias during renal replacement therapy. Nephron 1985;39:356–60. DOI: https://doi.org/10.1159/000183405

Rantanen JM, Riahi S, Schmidt EB, Johansen MB, Søgaard P, Christensen JH. Arrhythmias in Patients on Maintenance Dialysis: A Cross-sectional Study. Am J Kidney Dis. 2020 Feb;75(2):214-24. doi: 10.1053/j.ajkd.2019.06.012. DOI: https://doi.org/10.1053/j.ajkd.2019.06.012

Hamadou B, Halle MP, Kamdem, F, Mbia MA, Amougou SN, Boombhi J, et al. Cardiac Arrhythmia during Chronic Hemodialysis: A Cross-Sectional Holter ECG Study in Patients from North Cameroon. Health Sciences and Disease. 2017;18(3):46-50.

Bozbas H, Atar I, Yildirir A, Ozgul A, Uyar M, Ozdemir N, et al. Prevalence and Predictors of Arrhythmia in End Stage Renal Disease Patients on Hemodialysis. Renal Failure 2009;29(3):331-9. DOI: https://doi.org/10.1080/08860220701191237

Erem C, Kulan K, Tuncer C, Bostan M, Mocan Z, Komsuoglu B. Cardiac arrhythmias in patients on maintenance hemodialysis. Acta Cardiologica 1997;52(1):25-36.

Wong MC, Kalman JM, Pedagogos E, Toussaint N, Vohra JK, Sparks PB, et al. Temporal distribution of arrhythmic events in chronic kidney disease: Highest incidence in the long interdialytic period. Heart Rhythm 2015;12:2047–55. DOI: https://doi.org/10.1016/j.hrthm.2015.06.033

Goldstein BA, Arce CM, Hlatky MA, Turakhia M, Setoguchi S, Winkelmayer WC. Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Circulation 2012;126:2293-301. DOI: https://doi.org/10.1161/CIRCULATIONAHA.112.099606

Winkelmayer WC, Patrick AR, Liu J, Brookhart MA, Setoguchi S. The increasing prevalence of atrial fibrillation among hemodialysis patients. Journal American Society of Nephrology 2011;22:349–57. DOI: https://doi.org/10.1681/ASN.2010050459

Zimmerman D, Sood MM, Rigatto C, Holden RM, Hiremath S, Clase CM. Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. Nephrology Dialysis Transplant 2012;27:3816–22. DOI: https://doi.org/10.1093/ndt/gfs416

Kaze FF, Kengne A-P, Djalloh AMA, Ashuntantang G, Halle MP, Menanga AP, et al. Pattern and correlates of cardiac lesions in a group of sub-Saharan African patients on maintenance hemodialysis. Pan Afr Med J. 2014 Jan 1;17(1). doi: 10.11604/pamj.2014.17.3.3422. DOI: https://doi.org/10.11604/pamj.2014.17.3.3422

Acar G, Akçay A, Sökmen A, Sökmen G, Köroğlu S, Nacar AB, et al. Hemodiyaliz hastalarında atriyal fibrilasyon sıklığı ve belirleyicileri. Türk Kardiyol Dern Arş. 2010;38(1):8-13.

Downloads

Published

2023-01-19

Issue

Section

Research Article

How to Cite

1.
Yurdam FS, Kış M. Frequency and type of arrhythmia in Holter electrocardiogram in patients undergoing hemodialysis: Hemodialysis patients – arrhythmia . J Surg Med [Internet]. 2023 Jan. 19 [cited 2024 Apr. 23];7(1):75-8. Available from: https://jsurgmed.com/article/view/7584